Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.61 |
| ▸ | MAPT | P10636 | 4/20 | 0.61 |
| ▸ | TYMS | P04818 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CTSB | P07858 | 1/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30997742 | 1.00 | ALDH1A1 (0.61) | ALDH1A1MAPTTYMSPKMMAPK1 | |
| SCHEMBL3519263 | 0.92 | MAPT (0.57) | ALDH1A1MAPTTYMSPKMMAPK1 | |
| SCHEMBL4614040 | 0.85 | ALDH1A1 (0.50) | ALDH1A1MAPTTYMSPKMMAPK1 | |
| SCHEMBL31335752 | 0.82 | MAPT (0.60) | ALDH1A1MAPTTYMSPKM | |
| SCHEMBL29557821 | 0.82 | MAPT (0.60) | ALDH1A1MAPTTYMSPKM | |
| SCHEMBL417912 | 0.82 | MAPT (0.60) | ALDH1A1MAPTTYMSPKM | |
| SCHEMBL34474086 | 0.82 | MAPT (0.51) | ALDH1A1MAPTTYMSPKMMAPK1 | |
| SCHEMBL7162505 | 0.81 | TYMS (0.53) | ALDH1A1MAPTTYMSPKMMAPK1 | |
| SCHEMBL1090688 | 0.81 | ALDH1A1 (0.51) | ALDH1A1MAPTTYMSPKMMAPK1 | |
| SCHEMBL9452645 | 0.81 | ALDH1A1 (0.52) | ALDH1A1MAPTPKMMAPK1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11453628-B2 | Condensed cyclic compound, composition including the same, and organic light-emitting device including thin film formed from the composition | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-09-27 | — | — | US | disclosed |
| EP-3822258-B1 | CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THIN FILM FORMED FROM THE COMPOSITION | SAMSUNG DISPLAY CO LTD (KR) | 2022-06-15 | — | — | EP | disclosed |
| CN-111269078-A | Condensed-cyclic compound, composition comprising the same, and organic light-emitting device | 三星显示有限公司 | 2020-06-12 | — | — | CN | disclosed |
| US-20200181045-A1 | CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THIN FILM FORMED FROM THE COMPOSITION | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11453628-B2 | Condensed cyclic compound, composition including the same, and organic light-emitting device including thin film formed from the composition | CRY1, CRY2, NCAPH | ALDH1A1 2800/4885MAPT 270/4885TYMS 2725/4885 |
| US-20200181045-A1 | CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THIN FILM FORMED FROM THE COMPOSITION | CRY1, CRY2, NCAPH | ALDH1A1 2800/4885MAPT 270/4885TYMS 2725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.